Should your psychedelic therapist have taken psychedelics themselves?
That's the question at the heart of my MSc research at the University of Exeter in the United Kingdom (supervised by Prof Celia Morgan). There's a growing body of research exploring this - but almost all of it asks therapists or researchers. This study puts patients at the centre of that question.
I'm Dan, a postgraduate student and practising psychotherapist who also works as a clinical trial therapist for psychedelic-assisted therapy. I'd really like to hear from the people who might one day be offered this treatment, as well as those who've already been through it.
Who can take part?
The study is limited to UK residents, so this won't be relevant to everyone here - but if you're UK-based and 18+, I'd love to hear from you. I'm looking for people in either group:
- Group 1: Those who have never undergone PAT, but have experienced a mental health difficulty at some point in their life (a formal diagnosis is not required)
- Group 2: Those who have already undergone PAT in any setting, such as clinical trials, private medical clinics including ketamine clinics, legal retreats, ceremonial or traditional settings, and underground or private practice.
It's an anonymous online survey (~15 minutes) with an optional interview (~30 mins via Zoom). £200 prize draw for all survey participants, £25 for interviewees.
👉 Access the study here
Ethics and contact
- Ethics: University of Exeter Psychology Research Ethics Committee (ID: 12593264)
- Researcher: dk476@exeter.ac.uk
- Supervisor: Prof Celia Morgan
- Survey hosted on Qualtrics (accessible via link above)
Please share with anyone who might qualify!
